A Non-interventional Study of Melphalan Flufenamide (Melflufen) (Pepaxti®) and Dexamethasone in Patients With Relapsed and/or Refractory Multiple Myeloma (R/RMM)
Clinical trial NCT07559799 · RECRUITING
Trial details
- NCT number
- NCT07559799
- Sponsor
- iOMEDICO AG
- Status
- RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2026-06-01
- Primary completion
- 2029-08-30
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.